Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Uptake of medicines and prescribing patterns in the palliative care schedule of the Pharmaceutical Benefits Scheme.

Currow DC, Sansom LN.

Med J Aust. 2014 Jun 2;200(10):560-1. No abstract available.

PMID:
24882473
2.
3.

Hospitalization rates as outcome indicators of national medicinal drug policies: the example of gastrointestinal ulcer.

Roughead EE, Gilbert AL, Primrose JG, Sansom LN.

Pharmacoepidemiol Drug Saf. 1999 Jul;8(4):291-9.

PMID:
15073922
4.

Surfing, self-medicating and safety: buying non-prescription and complementary medicines via the internet.

Bessell TL, Anderson JN, Silagy CA, Sansom LN, Hiller JE.

Qual Saf Health Care. 2003 Apr;12(2):88-92.

5.

Quality of global e-pharmacies: can we safeguard consumers?

Bessell TL, Silagy CA, Anderson JN, Hiller JE, Sansom LN.

Eur J Clin Pharmacol. 2002 Dec;58(9):567-72. Epub 2002 Oct 29.

PMID:
12483449
6.

Prevalence of South Australia's online health seekers.

Bessell TL, Silagy CA, Anderson JN, Hiller JE, Sansom LN.

Aust N Z J Public Health. 2002 Apr;26(2):170-3.

PMID:
12054338
7.

Do Internet interventions for consumers cause more harm than good? A systematic review.

Bessell TL, McDonald S, Silagy CA, Anderson JN, Hiller JE, Sansom LN.

Health Expect. 2002 Mar;5(1):28-37. Review.

8.

'Pharmacist only' medicines.

Bessell TL, Hiller JE, Sansom LN.

Aust N Z J Public Health. 1999 Dec;23(6):661-2.

PMID:
10641363
9.

Drug-related hospital admissions: a review of Australian studies published 1988-1996.

Roughead EE, Gilbert AL, Primrose JG, Sansom LN.

Med J Aust. 1998 Apr 20;168(8):405-8.

PMID:
9594953
10.

The effects of cyclophosphamide on the pharmacokinetics of triiodothyronine in the male rat.

Angley MT, Sansom LN, Smeaton TC, Stupans I.

J Pharm Pharmacol. 1996 Apr;48(4):386-9.

PMID:
8794988
11.

The effect of hypoxaemia on drug disposition in chronic respiratory failure.

Rowett D, Latimer K, Sansom LN, Ruffin RE, May F, Henderson G, Hayball PJ.

Eur J Clin Pharmacol. 1996;50(1-2):77-82.

PMID:
8739815
13.

Human pharmacokinetics of tiludronate.

Sansom LN, Necciari J, Thiercelin JF.

Bone. 1995 Nov;17(5 Suppl):479S-483S.

PMID:
8573422
14.

What is the true clinical significance of plasma protein binding displacement interactions?

Sansom LN, Evans AM.

Drug Saf. 1995 Apr;12(4):227-33. Review. No abstract available.

PMID:
7646820
15.

Bioequivalence requirements for generic products.

Nation RL, Sansom LN.

Pharmacol Ther. 1994 Apr-May;62(1-2):41-55. Review.

PMID:
7991647
16.

The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.

Hayball PJ, Nation RL, Bochner F, Sansom LN, Ahern MJ, Smith MD.

Br J Clin Pharmacol. 1993 Sep;36(3):185-93.

17.

Identification of two human brain aryl sulfotransferase cDNAs.

Zhu X, Veronese ME, Bernard CC, Sansom LN, McManus ME.

Biochem Biophys Res Commun. 1993 Aug 31;195(1):120-7.

PMID:
8363592
18.

Molecular characterisation of a human aryl sulfotransferase cDNA.

Zhu X, Veronese ME, Sansom LN, McManus ME.

Biochem Biophys Res Commun. 1993 Apr 30;192(2):671-6.

PMID:
8484775
19.

cDNA expression studies of rat liver aryl sulphotransferase.

Cruickshank D, Sansom LN, Veronese ME, Mojarrabi B, McManus ME, Zhu X.

Biochem Biophys Res Commun. 1993 Feb 26;191(1):295-301.

PMID:
8447833
20.

Co-regulation of phenytoin and tolbutamide metabolism in humans.

Tassaneeyakul W, Veronese ME, Birkett DJ, Doecke CJ, McManus ME, Sansom LN, Miners JO.

Br J Clin Pharmacol. 1992 Dec;34(6):494-8.

21.

The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycin.

Stupans I, Sansom LN.

Biochem Pharmacol. 1991 Nov 6;42(11):2085-90.

PMID:
1958226
22.

Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.

Mandema JW, Sansom LN, Dios-Vièitez MC, Hollander-Jansen M, Danhof M.

J Pharmacol Exp Ther. 1991 Apr;257(1):472-8.

PMID:
1850477
23.

Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.

Doecke CJ, Veronese ME, Pond SM, Miners JO, Birkett DJ, Sansom LN, McManus ME.

Br J Clin Pharmacol. 1991 Feb;31(2):125-30.

25.

The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans.

Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi AA.

Biopharm Drug Dispos. 1990 Aug-Sep;11(6):507-18.

PMID:
2207301
26.

Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studies.

West RJ, Boehm G, Dwyer M, Williams DB, Sansom LN, Penna AC.

Biopharm Drug Dispos. 1990 Mar;11(2):165-77.

PMID:
2328301
27.

Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomes.

Doecke CJ, Sansom LN, McManus ME.

Biochem Biophys Res Commun. 1990 Jan 30;166(2):860-6.

PMID:
2405858
28.

Plasma and cerebrospinal fluid concentration of temazepam following oral drug administration.

Badcock NR, Osborne GA, Nyman TL, Sansom LN, Russell WJ, Frewin DB.

Eur J Clin Pharmacol. 1990;38(2):153-5.

PMID:
1970959
29.

Lack of effect of co-trimoxazole on the pharmacokinetics of orally administered theophylline.

Lo KF, Nation L, Sansom LN.

Biopharm Drug Dispos. 1989 Nov-Dec;10(6):573-80.

PMID:
2611358
30.

Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen.

Evans AM, Nation RL, Sansom LN.

Br J Clin Pharmacol. 1989 Aug;28(2):143-9.

31.

Stereoselective plasma protein binding of ibuprofen enantiomers.

Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi AA.

Eur J Clin Pharmacol. 1989;36(3):283-90.

PMID:
2744069
32.

Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi AA.

Br J Clin Pharmacol. 1988 Dec;26(6):771-80.

33.

Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin.

Milne RW, Coulthard K, Nation RL, Penna AC, Roberts G, Sansom LN.

Br J Clin Pharmacol. 1988 Sep;26(3):330-3.

34.

Pharmacokinetics of a new sublingual formulation of temazepam.

Russell WJ, Badcock NR, Frewin DB, Sansom LN.

Eur J Clin Pharmacol. 1988;35(4):437-9.

PMID:
2904371
35.

The pharmacokinetics of ketoconazole after chronic administration in adults.

Badcock NR, Bartholomeusz FD, Frewin DB, Sansom LN, Reid JG.

Eur J Clin Pharmacol. 1987;33(5):531-4.

PMID:
3428348
36.

Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administration.

Jones TE, Milne RW, Mudaliar Y, Sansom LN.

Antimicrob Agents Chemother. 1985 Aug;28(2):293-8.

37.

Aspirin metabolites causing misinterpretation of paracetamol results.

Badcock NR, Penna AC, Everett DS, Sansom LN.

Ann Clin Biochem. 1984 Nov;21 ( Pt 6):527-30.

PMID:
6517496
38.

Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.

O'Leary TD, Sansom LN.

J Pharmacol Exp Ther. 1981 Mar;216(3):613-6.

PMID:
6782238
39.
40.

Interaction between phenytoin and valproate.

Sansom LN, Beran RC, Schapel GJ.

Med J Aust. 1980 Aug 23;2(4):212.

PMID:
6776391
41.

Pharmacokinetics of sodium valproate in epileptic patients: prediction of maintenance dosage by single-dose study.

Schapel GJ, Beran RG, Doecke CJ, O'Reilly WJ, Reece PA, Rischbieth RH, Sansom LN, Stanley PE.

Eur J Clin Pharmacol. 1980 Jan;17(1):71-7. No abstract available.

PMID:
6768573
42.

Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.

Sansom LN, Milne RW, Cooper D.

Eur J Clin Pharmacol. 1979;16(6):417-21.

PMID:
583332
43.

Some aspects of the stability of parenteral nutrition solutions.

West KR, Sansom LN, Cosh DG, Thomas MP.

Pharm Acta Helv. 1976;51(1):19-22. No abstract available.

PMID:
821062
44.

Bioavailability of phenytoin from various pharmaceutical preparations in children.

Manson JI, Beal SM, Magarey A, Pollard AC, O'Reilly WJ, Sansom LN.

Med J Aust. 1975 Oct 11;2(15):590-2.

PMID:
1196223
45.

Plasma phenytoin levels produced by various phenytoin preparations.

Sansom LN, O'Reilly WJ, Wiseman CW, Stern LM, Derham J.

Med J Aust. 1975 Oct 11;2(15):593-5.

PMID:
1105111
46.

A problem when ampoules are opened.

Burke DT, Porter KS, Sansom LN.

Med J Aust. 1972 Nov 11;2(20):1128-9. No abstract available.

PMID:
4640571
47.

Interaction of proflavine and 9-aminoacridine with DNA at temperatures below and above the melting temperature.

Jordan DO, Sansom LN.

Biopolymers. 1971;10(2):399-410. No abstract available.

PMID:
4925713

Supplemental Content

Loading ...
Support Center